tetano
Editor, Senior Moderator
Vet Microbiol. 2016 Nov 24. pii: S0378-1135(16)30703-9. doi: 10.1016/j.vetmic.2016.11.025. [Epub ahead of print]
[h=1]Recombinant viral-vectored vaccines for the control of avian influenza in poultry.[/h] Suarez DL[SUP]1[/SUP], Pantin-Jackwood MJ[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Vaccination is a commonly used tool for the control of both low pathogenic and highly pathogenic avian influenza (AI) viruses. Traditionally, inactivated adjuvanted vaccines made from a low pathogenic field strain have been used for vaccination, but advances in molecular biology have allowed a number of different viral vectored vaccines, expressing the AI virus hemagglutinin (HA) gene, to be developed and licensed for use for control of AI. This review summarizes the licensed vector vaccines available for use in poultry. As a group, these vaccines can stimulate both a cellular and humoral immune response and, when antigenically well matched to the target AI strain, are effective at preventing clinical disease and reducing virus shedding if vaccinated birds do become infected. The vaccines can often be given to one-day old chicks in the hatchery, which can provide early protection and is a cost effective route of administration of the vaccine. All the licensed vectored vaccines, because they only express the HA gene, can potentially be used to differentiate vaccinated from vaccinated and infected birds, which is often referred to as a DIVA strategy. Although a potentially valuable tool for the surveillance of the virus in countries that vaccinate, the DIVA principle has currently not been applied. Concern remains that maternal antibody or pre-existing immunity to the vector or to the AI HA insert can suppress the immune response to the vaccine. The viral vectored vaccines appear to work well with a prime boost strategy where the vectored vaccine is given first and a different type of vaccine, often a killed adjuvanted vaccine is given two or three weeks later.
Copyright © 2016. Published by Elsevier B.V.
[h=4]KEYWORDS:[/h] Avian influenza; Immunity; Poultry; Vaccine; Viral vectored
PMID: 27916319 DOI: 10.1016/j.vetmic.2016.11.025
[PubMed - as supplied by publisher]
[h=1]Recombinant viral-vectored vaccines for the control of avian influenza in poultry.[/h] Suarez DL[SUP]1[/SUP], Pantin-Jackwood MJ[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Vaccination is a commonly used tool for the control of both low pathogenic and highly pathogenic avian influenza (AI) viruses. Traditionally, inactivated adjuvanted vaccines made from a low pathogenic field strain have been used for vaccination, but advances in molecular biology have allowed a number of different viral vectored vaccines, expressing the AI virus hemagglutinin (HA) gene, to be developed and licensed for use for control of AI. This review summarizes the licensed vector vaccines available for use in poultry. As a group, these vaccines can stimulate both a cellular and humoral immune response and, when antigenically well matched to the target AI strain, are effective at preventing clinical disease and reducing virus shedding if vaccinated birds do become infected. The vaccines can often be given to one-day old chicks in the hatchery, which can provide early protection and is a cost effective route of administration of the vaccine. All the licensed vectored vaccines, because they only express the HA gene, can potentially be used to differentiate vaccinated from vaccinated and infected birds, which is often referred to as a DIVA strategy. Although a potentially valuable tool for the surveillance of the virus in countries that vaccinate, the DIVA principle has currently not been applied. Concern remains that maternal antibody or pre-existing immunity to the vector or to the AI HA insert can suppress the immune response to the vaccine. The viral vectored vaccines appear to work well with a prime boost strategy where the vectored vaccine is given first and a different type of vaccine, often a killed adjuvanted vaccine is given two or three weeks later.
Copyright © 2016. Published by Elsevier B.V.
[h=4]KEYWORDS:[/h] Avian influenza; Immunity; Poultry; Vaccine; Viral vectored
PMID: 27916319 DOI: 10.1016/j.vetmic.2016.11.025
[PubMed - as supplied by publisher]